Table 1.
Summary of transcriptome datasets with IL-6 treatment used in this study. The numbers of experiment and control indicate the replicates in each dataset. All treatment used exogenous IL-6 except the * and # marked one. *, IL-6 receptor antibody; #, IL-6 level determined in patients. (-1/2/3 in the same Datasets were different treatment experiments).
| Datasets | Experiment | Control | Sample | Treatment |
|---|---|---|---|---|
| GSE76340 | 3 | 3 | Immature dendritic cells | TNF-α, IL-1, IL-6, prostaglandin E2 and IFN-γ |
| GSE68942-1 | 3 | 3 | HK-2 | IFN/IL6 |
| GSE68942-2 | 3 | 3 | HK-2 | IFN/TNF/IL6 |
| GSE68941 | 3 | 3 | HK-2 | TNF/IL6 |
| GSE68940 | 3 | 3 | HK-2 | IL6 |
| GSE62941-1 | 3 | 3 | KPL4 | Medi5117 |
| GSE62941-2 | 3 | 3 | NCI-H1650 | Medi5117 |
| GSE62941-3 | 3 | 3 | DU145 | Medi5117 |
| GSE29793 | 3 | 3 | INA6 | withdraw IL6 |
| GSE45466 | 8 | 8 | Monocyte-derived dendritic cell | IL6 |
| GSE12385 | 18 | 18 | PMBC | IL6 level |
| GSE10685 | 3 | 3 | Human skeletal muscle | IL6 |
| GSE8515 | 5 | 5 | macrophage | IL6 |